Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1995 Apr;4(4):773–780. doi: 10.1002/pro.5560040417

Thrombin inhibition by cyclic peptides from thrombomodulin.

J C Lougheed 1, C L Bowman 1, D P Meininger 1, E A Komives 1
PMCID: PMC2143091  PMID: 7613475

Abstract

Peptides corresponding to the loop regions of the fourth, fifth, and sixth epidermal growth factor (EGF)-like domains of thrombomodulin (TM) have been synthesized and assayed for thrombin inhibition, as indicated by both inhibition of thrombin-mediated fibrinogen clotting and inhibition of the association of thrombin with TM that results in protein C activation. Peptides from the fifth EGF-like domain showed significant inhibition of fibrinogen clotting and protein C activation, whereas peptides from the fourth and sixth EGF-like domains were weak inhibitors in both assays. Two structural features were important for inhibitory potency of the peptides from the fifth EGF-like domain: cyclization by a disulfide bond and attachment of the "tail" amino acids C-terminal to the disulfide loop. Linear control peptides did not significantly inhibit clotting or protein C activation. The C-terminal loop alone, the "tail" peptide, or a mixture of the two were at least 10-fold less potent inhibitors of clotting or protein C activation. A more constrained peptide analog was designed by deletion of an isoleucine within the C5-C6 disulfide loop, TM52-1 + 5C. This analog was a better inhibitor in both assay systems, having a Ki for protein C activation of 26 microM.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourin M. C., Ohlin A. K., Lane D. A., Stenflo J., Lindahl U. Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin. J Biol Chem. 1988 Jun 15;263(17):8044–8052. [PubMed] [Google Scholar]
  2. Clarke J. H., Light D. R., Blasko E., Parkinson J. F., Nagashima M., McLean K., Vilander L., Andrews W. H., Morser J., Glaser C. B. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem. 1993 Mar 25;268(9):6309–6315. [PubMed] [Google Scholar]
  3. Cooke R. M., Wilkinson A. J., Baron M., Pastore A., Tappin M. J., Campbell I. D., Gregory H., Sheard B. The solution structure of human epidermal growth factor. 1987 May 28-Jun 3Nature. 327(6120):339–341. doi: 10.1038/327339a0. [DOI] [PubMed] [Google Scholar]
  4. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  5. Esmon N. L. Thrombomodulin. Prog Hemost Thromb. 1989;9:29–55. [PubMed] [Google Scholar]
  6. Griffin J. H., Evatt B., Zimmerman T. S., Kleiss A. J., Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest. 1981 Nov;68(5):1370–1373. doi: 10.1172/JCI110385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hayashi T., Zushi M., Yamamoto S., Suzuki K. Further localization of binding sites for thrombin and protein C in human thrombomodulin. J Biol Chem. 1990 Nov 25;265(33):20156–20159. [PubMed] [Google Scholar]
  8. Hofsteenge J., Taguchi H., Stone S. R. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J. 1986 Jul 1;237(1):243–251. doi: 10.1042/bj2370243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kohda D., Go N., Hayashi K., Inagaki F. Tertiary structure of mouse epidermal growth factor determined by two-dimensional 1H NMR. J Biochem. 1988 May;103(5):741–743. doi: 10.1093/oxfordjournals.jbchem.a122338. [DOI] [PubMed] [Google Scholar]
  10. Kurosawa S., Galvin J. B., Esmon N. L., Esmon C. T. Proteolytic formation and properties of functional domains of thrombomodulin. J Biol Chem. 1987 Feb 15;262(5):2206–2212. [PubMed] [Google Scholar]
  11. Kurosawa S., Stearns D. J., Jackson K. W., Esmon C. T. A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site. J Biol Chem. 1988 May 5;263(13):5993–5996. [PubMed] [Google Scholar]
  12. Lentz S. R., Sadler J. E. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991 Dec;88(6):1906–1914. doi: 10.1172/JCI115514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Makino K., Morimoto M., Nishi M., Sakamoto S., Tamura A., Inooka H., Akasaka K. Proton nuclear magnetic resonance study on the solution conformation of human epidermal growth factor. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7841–7845. doi: 10.1073/pnas.84.22.7841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Montelione G. T., Wüthrich K., Nice E. C., Burgess A. W., Scheraga H. A. Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5226–5230. doi: 10.1073/pnas.84.15.5226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nagashima M., Lundh E., Leonard J. C., Morser J., Parkinson J. F. Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. J Biol Chem. 1993 Feb 5;268(4):2888–2892. [PubMed] [Google Scholar]
  16. Parkinson J. F., Grinnell B. W., Moore R. E., Hoskins J., Vlahos C. J., Bang N. U. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem. 1990 Jul 25;265(21):12602–12610. [PubMed] [Google Scholar]
  17. Srinivasan J., Hu S., Hrabal R., Zhu Y., Komives E. A., Ni F. Thrombin-bound structure of an EGF subdomain from human thrombomodulin determined by transferred nuclear Overhauser effects. Biochemistry. 1994 Nov 22;33(46):13553–13560. doi: 10.1021/bi00250a007. [DOI] [PubMed] [Google Scholar]
  18. Stearns D. J., Kurosawa S., Esmon C. T. Microthrombomodulin. Residues 310-486 from the epidermal growth factor precursor homology domain of thrombomodulin will accelerate protein C activation. J Biol Chem. 1989 Feb 25;264(6):3352–3356. [PubMed] [Google Scholar]
  19. Tsiang M., Lentz S. R., Dittman W. A., Wen D., Scarpati E. M., Sadler J. E. Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry. 1990 Nov 27;29(47):10602–10612. doi: 10.1021/bi00499a005. [DOI] [PubMed] [Google Scholar]
  20. Tsiang M., Lentz S. R., Sadler J. E. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J Biol Chem. 1992 Mar 25;267(9):6164–6170. [PubMed] [Google Scholar]
  21. Ye J., Esmon C. T., Johnson A. E. The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J Biol Chem. 1993 Feb 5;268(4):2373–2379. [PubMed] [Google Scholar]
  22. Ye J., Liu L. W., Esmon C. T., Johnson A. E. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem. 1992 Jun 5;267(16):11023–11028. [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES